Another company looking to initiate clinical trials with an epigenetic-editor-based treatment for hepatitis is nChroma Bio.

HBV=hepatitis B virus. HBVDR=HBV drug resistance ... Due to the overlapping reading frames in the HBV genome, RAMs in reverse transcriptase can also lead to changes in the overlapping surface antigen ...

Currently, there is no feline vaccine for the hepatitis B virus, and the hepatitis B vaccine for humans is highly toxic to ...

The U.S. capacity to battle hepatitis B and C has been leveled a devastating blow with the recent closure of the CDC’s ...

Researchers have shown that differences in the entire rotavirus genome—not just its two surface proteins—affect how well ...

An international team of researchers co-led by Job Dekker, Ph.D., at UMass Chan Medical School, have identified rules that ...

GSK has revealed updated results from its phase 2b trial of its antisense drug for hepatitis B virus (HBV) infections, which reveal a sharp decline in the proportion of patients with undetectable ...

Updated Hep B Vaccine More Effective for People With HIV Dec. 10, 2024 — A newer vaccine against hepatitis B virus was clearly superior to an older vaccine type in inducing a protective antibody ...

Interventions Identified to Eliminate Transmission of Hepatitis B in Africa Feb. 27, 2025 — A new study that has the potential to change the landscape of hepatitis B transmission in Africa.

Somchai, a Thai native, was 21 years old and faced a double threat to his long-term health and wellbeing. He was living with ...

Chronic HBV was associated with increased risk for adverse COVID-19 outcomes, but the risk was lower among coinfected patients vaccinated against COVID-19.